LINFOMAS Y TRASPLANTES
Cambridge University Hospitals NHS Foundation Trust
Cambridge, Reino UnidoPublications in collaboration with researchers from Cambridge University Hospitals NHS Foundation Trust (1)
2022
-
Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma
Blood, Vol. 140, Núm. 21, pp. 2248-2260